Seeking Only Good Companies
What is of concern to us is the very short memory of certain lawmakers and, even more concerning, the SEC. They want to cut back on or even repeal the 2002 Sarbanes-Oxley Act which has cleaned up balance sheets, installed new reporting processes, greatly improved corporate governance, and has been the catalyst behind most of the restatements by public companies during the last five years. No law is perfect, but from an investor perspective, this one rocks.
A frightening battle cry of the law makers and public servants trying to repeal or water down Sarbanes-Oxley is that too many firms are publicly listing their shares in London and other exchanges simply to avoid the cost and hassle of complying with Sarbanes-Oxley.
Late in April Greg Ip of Dow Jones published a report in the Wall Street Journal after reviewing raw data and academic analysis.
-
In a new study, they [three academics] conclude there is no evidence the much-criticized 2002 Sarbanes-Oxley Act, which beefed up corporate accounting and financial disclosures, among other things, increased London appeal to foreign companies at New York expense. The study looked at thousands of companies that either listed, or did not list, their stocks on various U.S. and London markets from 1990 to 2005.
The research also found that investors are still willing to pay a sizable premium for foreign-company shares listed in the U.S., in return for meeting tough U.S. regulatory standards. Foreign-company stocks in London receive no similar premium, they said.
The second implication from this study is perhaps more important: meeting tough regulatory standards is good for stock valuations. After the scandal-plagued market meltdown from 2000 through 2002, the regulatory environment from Sarbanes-Oxley has greatly improved transparency and trustworthiness. This in turn has helped drive the investment environment over the past four years of consistently strong stock returns with low volatility. After all, when companies are required to be more upfront about their financials, it logically follows that there are fewer and less severe negative surprises. The conclusion is clear: far from being a burden on Corporate America, Sarbanes-Oxley is actually a benefit to U.S. companies.
The article goes further and discusses the cyclical nature of new listings.
-
The researchers also say the decline in new foreign listings on U.S. stock markets since 2001 is not due to regulatory overkill. Rather, today there are simply fewer foreign companies that fit the historic profile for listing abroad: namely, larger, faster growing and less indebted companies from countries with stronger legal protections. Relative to historical patterns, the U.S. attracted more foreign companies since 2001 than would have been predicted, while London attracted slightly fewer.
All of our evidence is consistent with the theory that there is a distinct governance benefit for firms that list on the U.S. exchanges, say the authors, Andrew Karolyi and Rene Stulz of Ohio State University and Craig Doidge of the University of Toronto. There is no evidence this benefit has weakened over time.
The biggest proponent to loosening Sarbanes-Oxley is Christopher Cox of the SEC. He should know better and is not serving investors or the U.S. markets. For now, as stewards to institutional investors we will watch and chime in before we find ourselves once again in an Enron/Worldcom world.
In conclusion, there are plenty of good firms to purchase in the public markets. In fact the best firms do not mind complying with the laws that protect investors, and they trade at a premium for doing so.
As money managers utilizing multifactor models, we believe the cleaner the data into our models, the more accurate the results. So our affection for the law is both self serving and investor protection friendly.
